SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001404644-24-000057
Filing Date
2024-05-10
Accepted
2024-05-10 16:14:10
Documents
80
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ngne-20240331.htm   iXBRL 10-Q 1246135
2 EX-10.1 neurogeneemploymentagreemea.htm EX-10.1 80059
3 EX-10.2 neurogeneemploymentagreeme.htm EX-10.2 80221
4 EX-10.3 stuartcobbarconsultingagre.htm EX-10.3 75160
5 EX-31.1 ngne-2024formq110xqxex311p.htm EX-31.1 9562
6 EX-31.2 ngne-2024formq110xqxex312p.htm EX-31.2 9692
7 EX-32.1 ngne-2024formq110xqxex321.htm EX-32.1 7266
  Complete submission text file 0001404644-24-000057.txt   6320310

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20240331.xsd EX-101.SCH 42283
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngne-20240331_cal.xml EX-101.CAL 69839
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngne-20240331_def.xml EX-101.DEF 188787
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20240331_lab.xml EX-101.LAB 569927
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20240331_pre.xml EX-101.PRE 409560
84 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20240331_htm.xml XML 658668
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 24935005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)